• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10618
Device Problem Break (1069)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/25/2023
Event Type  malfunction  
Event Description
It was reported that shaft break occurred.The 10% stenosed target lesion was located in the mildly tortuous and mildly calcified coronary vessel.A 2.75 x 16 synergy ii drug-eluting stent was advanced to treat the lesion.Upon insertion, it was noticed that the shaft was fractured.The fractured device was removed.The procedure was completed with other device and there were no patient complications reported.
 
Manufacturer Narrative
Device evaluated by mfr.: synergy ous mr 2.75 x 16mm stent delivery system catheter was returned for analysis.Visual, tactile and microscopic analysis were performed on the device.Examination of the hypotube found a multiple kinks and breaks at 14cm, 25.7cm and 40.9cm distal to the distal end of the strain relief, 100.5cm from the distal markerband.Multiple kinks were identified along the polymer extrusion shaft.Examination of the stent found no issues.There was no sign of damage, stretching or lifting of the stent struts.Balloon cones were reviewed, and no issues were noted.Balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.No signs of movement, stent was set between the proximal and distal markerbands.Bumper tip showed no signs of distal tip damage.No other device issues were identified during returned product analysis.
 
Event Description
It was reported that shaft break occurred.The 10% stenosed target lesion was located in the mildly tortuous and mildly calcified coronary vessel.A 2.75 x 16 synergy ii drug-eluting stent was advanced to treat the lesion.Upon insertion, it was noticed that the shaft was fractured.The fractured device was removed.The procedure was completed with other device and there were no patient complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18346676
MDR Text Key330736397
Report Number2124215-2023-71006
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCO
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number10618
Device Catalogue Number10618
Device Lot Number0030514538
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/29/2023
Initial Date FDA Received12/18/2023
Supplement Dates Manufacturer Received02/15/2024
Supplement Dates FDA Received03/07/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/26/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-